首页> 外文期刊>Clinical & developmental immunology. >IL-27 Driven Upregulation of Surface HLA-E Expression on Monocytes Inhibits IFN-γ Release by Autologous NK Cells
【24h】

IL-27 Driven Upregulation of Surface HLA-E Expression on Monocytes Inhibits IFN-γ Release by Autologous NK Cells

机译:IL-27在单核细胞上的表面HLA-E表达驱动的上调抑制了自体NK细胞的IFN-γ释放

获取原文
获取外文期刊封面目录资料

摘要

HLA-G and HLA-E are HLA-Ib molecules with several immunoregulatory properties. Their cell surface expression can be modulated by different cytokines. Since IL-27 and IL-30 may either stimulate or regulate immune responses, we have here tested whether these cytokines may modulate HLA-G and -E expression and function on human monocytes. Monocytes expressed gp130 and WSX-1, the two chains of IL27 receptor (R), and IL6R α (that serves as IL-30R, in combination with gp130). However, only IL27R appeared to be functional, as witnessed by IL-27 driven STAT1/ STAT3 phosphorylation. IL-27, but not IL-30, significantly upregulated HLA-E (but not HLA-G) expression on monocytes. IFN- γ ; secretion by activated NK cells was dampened when the latter cells were cocultured with IL-27 pretreated autologous monocytes. Such effect was not achieved using untreated or IL-30 pretreated monocytes, thus indicating that IL-27 driven HLA-E upregulation might be involved, possibly through the interaction of this molecule with CD94/NKG2A inhibitory receptor on NK cells. In contrast, cytotoxic granules release by NK cell in response to K562 cells was unaffected in the presence of IL-27 pretreated monocytes. In conclusion, we delineated a novel immunoregulatory function of IL-27 involving HLA-E upregulation on monocytes that might in turn indirectly impair some NK cell functions.
机译:HLA-G和HLA-E是具有几种免疫调节性质的HLA-IB分子。它们的细胞表面表达可以通过不同的细胞因子调节。由于IL-27和IL-30可以刺激或调节免疫应答,因此我们在此测试这些细胞因子是否可以调节HLA-G和-E的表达和功能在人单核细胞上。单核细胞表达GP130和WSX-1,IL27受体(R)的两链和IL6Rα(用作IL-30R,与GP130组合)。然而,只有IL27R似乎是功能性的,所以通过IL-27驱动的Stat1 / Stat3磷酸化所目的。 IL-27,但不是IL-30,显着上调单核细胞的HLA-E(但不是HLA-G)表达。 IFN-γ;当用IL-27预处理的自体单核细胞与后一种细胞与IL-27预处理的自体单核细胞一起培养时,通过活化的NK细胞分泌。使用未处理的或IL-30预处理的单核细胞没有实现这种效果,从而表明可以涉及IL-27驱动的HLA-E上调,可能通过该分子与NK细胞上的CD94 / NKG2A抑制剂受体相互作用。相反,在IL-27预处理单核细胞存在下,NK细胞响应于K562细胞的细胞毒性颗粒释放。总之,我们描绘了IL-27的新型免疫调节功能,涉及HLA-E对单核细胞的UPROGURALE,其可能又抵抗一些NK细胞功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号